Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Deciphering the Role of Protein Kinase D1 (PKD1) in Cellular Proliferation.

Youssef I, Ricort JM.

Mol Cancer Res. 2019 Oct;17(10):1961-1974. doi: 10.1158/1541-7786.MCR-19-0125. Epub 2019 Jul 16. Review.

PMID:
31311827
2.

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

Spasojevic C, Marangoni E, Vacher S, Assayag F, Meseure D, Château-Joubert S, Humbert M, Karam M, Ricort JM, Auclair C, Regairaz M, Bièche I.

Oncotarget. 2018 May 1;9(33):23208-23219. doi: 10.18632/oncotarget.25292. eCollection 2018 May 1.

3.

Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.

Karam M, Bièche I, Legay C, Vacher S, Auclair C, Ricort JM.

J Cell Mol Med. 2014 Dec;18(12):2536-52. doi: 10.1111/jcmm.12322. Epub 2014 Oct 7.

4.

Effects of water soaking and/or sodium polystyrene sulfonate addition on potassium content of foods.

Picq C, Asplanato M, Bernillon N, Fabre C, Roubeix M, Ricort JM.

Int J Food Sci Nutr. 2014 Sep;65(6):673-7. doi: 10.3109/09637486.2014.908172. Epub 2014 Apr 10.

PMID:
24720622
5.

Insulin-like growth factor binding proteins increase intracellular calcium levels in two different cell lines.

Seurin D, Lombet A, Babajko S, Godeau F, Ricort JM.

PLoS One. 2013;8(3):e59323. doi: 10.1371/journal.pone.0059323. Epub 2013 Mar 19.

6.

Platelet-derived growth factor negatively regulates the insulin-like growth factor signaling pathway through the coordinated action of phosphatidylinositol 3-kinase and protein kinase C beta I.

Lassarre C, Legay C, Karam M, Ricort JM.

Biochim Biophys Acta. 2013 Jun;1833(6):1367-77. doi: 10.1016/j.bbamcr.2013.02.019. Epub 2013 Feb 24.

7.

Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.

Karam M, Legay C, Auclair C, Ricort JM.

Exp Cell Res. 2012 Mar 10;318(5):558-69. doi: 10.1016/j.yexcr.2012.01.001. Epub 2012 Jan 8.

PMID:
22245102
8.

Phosphatidylinositol 3-kinase and protein kinase D1 specifically cooperate to negatively regulate the insulin-like growth factor signaling pathway.

Karam M, Lassarre C, Legay C, Ricort JM.

Biochim Biophys Acta. 2012 Feb;1823(2):558-69. doi: 10.1016/j.bbamcr.2011.12.007. Epub 2011 Dec 29.

9.

Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development.

Netchine I, Azzi S, Houang M, Seurin D, Perin L, Ricort JM, Daubas C, Legay C, Mester J, Herich R, Godeau F, Le Bouc Y.

J Clin Endocrinol Metab. 2009 Oct;94(10):3913-21. doi: 10.1210/jc.2009-0452. Epub 2009 Sep 22.

PMID:
19773405
10.

Proteomics demonstration that normal breast epithelial cells can induce apoptosis of breast cancer cells through insulin-like growth factor-binding protein-3 and maspin.

Toillon RA, Lagadec C, Page A, Chopin V, Sautière PE, Ricort JM, Lemoine J, Zhang M, Hondermarck H, Le Bourhis X.

Mol Cell Proteomics. 2007 Jul;6(7):1239-47. Epub 2007 Apr 19.

11.
12.

Insulin-like growth factor binding protein (IGFBP) signalling.

Ricort JM.

Growth Horm IGF Res. 2004 Aug;14(4):277-86. Review. No abstract available.

PMID:
15231296
13.

Insulin-like growth factor binding protein-3 stimulates phosphatidylinositol 3-kinase in MCF-7 breast carcinoma cells.

Ricort JM, Binoux M.

Biochem Biophys Res Commun. 2004 Feb 20;314(4):1044-9.

PMID:
14751238
15.
16.

The amino-terminal region of insulin-like growth factor binding protein-3, (1-95)IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells.

Bernard L, Babajko S, Binoux M, Ricort JM.

Biochem Biophys Res Commun. 2002 Apr 26;293(1):55-60.

PMID:
12054563
17.

Molecular mechanism of insulin resistance.

Le Marchand-Brustel Y, Tanti JF, Grémeaux T, Ricort JM.

Ann Endocrinol (Paris). 2002 Apr;63(2 Pt 1):111-3. Review. No abstract available.

PMID:
11994671
18.
19.

Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling.

Toillon RA, Descamps S, Adriaenssens E, Ricort JM, Bernard D, Boilly B, Le Bourhis X.

Exp Cell Res. 2002 Apr 15;275(1):31-43.

PMID:
11925103
21.

From insulin receptor signalling to Glut 4 translocation abnormalities in obesity and insulin resistance.

Le Marchand-Brustel Y, Tanti JF, Cormont M, Ricort JM, Grémeaux T, Grillo S.

J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):217-28. Review.

PMID:
10071760
22.

Cross-talk between the platelet-derived growth factor and the insulin signaling pathways in 3T3-L1 adipocytes.

Ricort JM, Tanti JF, Van Obberghen E, Le Marchand-Brustel Y.

J Biol Chem. 1997 Aug 8;272(32):19814-8.

24.

Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes.

Ricort JM, Tanti JF, Van Obberghen E, Le Marchand-Brustel Y.

Diabetologia. 1995 Oct;38(10):1148-56.

PMID:
8690166
25.

Parallel changes in Glut 4 and Rab4 movements in two insulin-resistant states.

Ricort JM, Tanti JF, Cormont M, Van Obberghen E, Le Marchand-Brustel Y.

FEBS Lett. 1994 Jun 20;347(1):42-4.

Supplemental Content

Loading ...
Support Center